Pharmaron Holdings Ltd. has acquired Bridge Laboratories China, a provider of GLP-compliant toxicology services to pharma and biopharmaceutical companies. With this acquisition, Pharmaron becomes an integrated CRO in China supporting clients with drug discovery and development processes in support of IND filings. Bridge Laboratories China has 84,000 sq. ft. of facilities, including animal vivariums that are both AAALAC multi-species accredited and U.S. GLP-compliant. Terms of the acquisition wer...